Profhilo dermal filler delivers great results as a treatment on its own or in combination with other aesthetics treatments currently on offer.
Profhilo Dermal Filler
PLEASE LOG IN TO PURCHASE
Profhilo is the first BDDE-free stabilised injectable hyaluronic acid (HA) based product for treating skin laxity.
With one of the highest concentrations of HA on the market (64mg / 2ml) it is not only boosting and hydrating the skin but also remodels the ageing and sagging tissue.
Profhilo delivers great results as a treatment on its own or in combination with other aesthetics treatments currently on offer.
Profhilo Mechanism of action
Profhilo is not a dermal filler but is marketed as a treatment for skin laxity. It is highly purified and extremely biocompatible due to the lack of chemical cross linking agents in it’s formula. This gives the product the advantages of being highly safe with reduced post procedure inflammation and low risk of any negative effects.
Profhilo uses patented thermal technology to bond low molecular weight hyaluronic acid to high molecular weight hyaluronic acid forming a large polymer which is more difficult for the body to destroy. This unique process and formulation allows for a concentration of 64mg/2ml of the High/Low molecular weight complex which is the highest concentration available of HA on the market. Within this hybrid molecule the high molecule weight HA acts as the building blocks of the face and the low molecular weight HA serves to regenerate the skin. Two treatment’s are usually given one month apart initially, then top ups can be given on an as required basis with the treatment duration usually being 6 months.
To summarize, Profhilo is a dual action treatment with the longer lasting effects resulting from the high molecular weight HA acting as dermal scaffold and the hydration and stimulation effects resulting from the low molecular weight portion of the hybrid polymer.